Our providers offer individualized care and competitive rates
However, our analysis revealed the opposite: patients with diabetes who were exposed to GLP-1 RAs had a substantially higher risk of being diagnosed with nAMD, with a shorter time to diagnosis, compared with propensity-matched patients who were unexposed. The researchers also revealed that this finding comes amid numerous reports in other literature of unexpected worsening of diabetic retinopathy following a rapid reduction in blood glucose levels
April 2026: There are now 73 pending lawsuits in MDL -3163 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , which involves NAION claims against Rybelsus and other GLP-1 drugs
The clinic's proximity to major employers in the Sorrento Valley and UTC area makes it particularly appealing to professionals seeking medical weight loss solutions without lengthy commutes to downtown San Diego medical centers
These minor side effects include a lack of appetite, nausea, vomiting, diarrhea, headaches, fatigue, and dizziness